Fluorescence-labeled methylation-sensitive amplified fragment length polymorphism (FL-MS-AFLP) analysis for quantitative determination of DNA methylation and demethylation status

Japanese Journal of Clinical Oncology

Volumn 38, Issue 4, 2008, Pages 317-322

  Kageyama, Shinji ^a,b   Shinmura, Kazuya ^a   Yamamoto, Hiroko ^a,b   Goto, Masanori ^a   Suzuki, Koichi ^c   Tanioka, Fumihiko ^a,d   Tsuneyoshi, Toshihiro ^b   Sugimura, Haruhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIZUOKA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d Iwata City Hospital   (Japan)

Author keywords

DNA fingerprinting; FL MS AFLP; Gastric cancer; Hypermethylation; Hypomethylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; FLUORESCENT DYE;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA FINGERPRINTING; DNA METHYLATION; ELECTROPHORESIS; FLUORESCENCE ANALYSIS; GENE LOCUS; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; LUNG CANCER; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; STOMACH CANCER;

CELL LINE, TUMOR; CPG ISLANDS; DNA FINGERPRINTING; DNA METHYLATION; FLUORESCENT DYES; HUMANS; JAPAN; LUNG NEOPLASMS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STAINING AND LABELING; STOMACH NEOPLASMS;

EID: 42549087839     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn021     Document Type: Article

References (13)

1. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005;5:223-31.
2. Miyamoto K, Ushijima T. Diagnostic and therapeutic applications of epigenetics. Jpn J Clin Oncol 2005;35:293-301.
3. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007;8:286-98.
4. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-53.
5. Hoffmann MJ, Schulz WA. Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 2005;83: 296-321.
6. Yamamoto F, Yamamoto M, Soto JL, Kojima E, Wang EN, Perucho M, et al. NotI-MseI methylation-sensitive amplified fragment length polymorphism for DNA methylation analysis of human cancers. Electrophoresis 2001;22:1946-56.
7. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K, et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006;9: 199-207.
8. Wang J, Kataoka H, Suzuki M, Sato N, Nakamura R, Tao H, et al. Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene 2005;24:5637-47.
9. Shinmura K, Tao H, Goto M, Igarashi H, Taniguchi T, Maekawa M, et al. Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer. Carcinogenesis 2004;25:2311-7.
10. Woodson K, Mason J, Choi SW, Hartman T, T angrea J, Virtamo J, et al. Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer: Cancer Epidemiol Biomarkers Prev 2001;10:69-74.
11. Reddy AN, Jiang WW, Kim M, Benoit N, Taylor R, Clinger J, et al. Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res 2003;63:7694-8.
12. Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, et al. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 2005;11:2466-70.
13. Nomoto K, Maekawa K Sugano K, Ushiama M, Fukayama N, Fujita S, et al. Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP. Jpn J Clin Oncol 2002;32:3-8.